Evidence map›Paper›PMID 36211427›Full record

ArticleFrontiers in immunology2022

Process development and preclinical evaluation of a major

Anjali Somanathan, Syed Yusuf Mian, Kritika Chaddha, Seemalata Uchoi, Praveen K Bharti, Ravi Tandon, Deepak Gaur, Virander Singh Chauhan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Host-parasite interactions duringFrontiers in immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Anjali SomanathanLaboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Syed Yusuf MianLaboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Kritika ChaddhaLaboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Seemalata UchoiLaboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Praveen K BhartiICMR-National Institute of Research in Tribal Health (NIRTH), Jabalpur, India.
Ravi TandonLaboratory of AIDS Research and Immunology, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Deepak GaurLaboratory of Malaria and Vaccine Research, School of Biotechnology, Jawaharlal Nehru University, New Delhi, India.
Virander Singh ChauhanMalaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India.
Jawaharlal Nehru University · INInternational Centre for Genetic Engineering and Biotechnology · INNational Institute for Research in Tribal Health · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MalariaMalaria VaccinesAluminum HydroxideAnimalsAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ProtozoanCysteineCytokinesEscherichia coliFreund's AdjuvantHumansMicePlasmodium falciparumAluminum HydroxideAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ProtozoanCysteineCytokinesFreund's AdjuvantMalaria VaccinesadjuvantsCyRPAE. colifermentationgiahumoral and cellular responsePlasmodium falciparumrecombinant subunit malaria vaccines

Identifiers

PMID36211427
PMCPMC9535676
OpenAlexW4296614640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.